Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, United States.
Biochemistry. 2011 Sep 6;50(35):7546-56. doi: 10.1021/bi2009135. Epub 2011 Aug 10.
Human interleukin-5 receptor α (IL5Rα) is a glycoprotein that contains four N-glycosylation sites in the extracellular region. Previously, we found that enzymatic deglycosylation of IL5Rα resulted in complete loss of IL5 binding. To localize the functionally important carbohydrate moieties, we employed site-directed mutagenesis at the N-glycosylation sites (Asn(15), Asn(111), Asn(196), and Asn(224)). Because Asn-to-Gln mutagenesis caused a significant loss of structural integrity, we used diverse mutations to identify stability-preserving changes. We also rationally designed mutations at and around the N-glycosylation sites based on sequence alignment with mouse IL5Rα and other cytokine receptors. These approaches were most successful at Asn(15), Asn(111), and Asn(224). In contrast, any replacement at Asn(196) severely reduced stability, with the N196T mutant having a reduced binding affinity for IL5 and diminished biological activity because of the lack of cell surface expression. Lectin inhibition analysis suggested that the carbohydrate at Asn(196) is unlikely involved in direct ligand binding. Taking this into account, we constructed a stable variant, with triple mutational deglycosylation (N15D, I109V/V110T/N111D, and L223R/N224Q). The re-engineered protein retained Asn(196) while the other three glycosylation sites were eliminated. This mostly deglycosylated variant had the same ligand binding affinity and biological activity as fully glycosylated IL5Rα, thus demonstrating a unique role for Asn(196) glycosylation in IL5Rα function. The results suggest that unique carbohydrate groups in multiglycosylated receptors can be utilized asymmetrically for function.
人白细胞介素-5 受体 α(IL5Rα)是一种糖蛋白,在细胞外区域含有四个 N-糖基化位点。以前,我们发现 IL5Rα 的酶促去糖基化导致 IL5 结合完全丧失。为了定位功能重要的碳水化合物部分,我们在 N-糖基化位点(Asn(15)、Asn(111)、Asn(196)和 Asn(224))进行了定点突变。由于 Asn 到 Gln 的突变导致结构完整性显著丧失,因此我们使用多种突变来识别稳定的变化。我们还根据与小鼠 IL5Rα 和其他细胞因子受体的序列比对,在 N-糖基化位点及其周围进行了合理设计的突变。这些方法在 Asn(15)、Asn(111)和 Asn(224)处最为成功。相比之下,Asn(196)的任何替换都会严重降低稳定性,而 N196T 突变体由于缺乏细胞表面表达,IL5 的结合亲和力降低,生物活性降低。凝集素抑制分析表明,Asn(196)的碳水化合物不太可能直接参与配体结合。考虑到这一点,我们构建了一个稳定的变体,具有三重突变去糖基化(N15D、I109V/V110T/N111D 和 L223R/N224Q)。该重新设计的蛋白质保留了 Asn(196),而其他三个糖基化位点被消除。这种大部分去糖基化的变体与完全糖基化的 IL5Rα 具有相同的配体结合亲和力和生物活性,因此证明了 Asn(196)糖基化在 IL5Rα 功能中的独特作用。结果表明,多糖基化受体中的独特碳水化合物基团可以不对称地用于功能。